Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Journal of Neuro-Oncology|November 10, 2016
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant gliomaEdward Pan, Jeffrey G Supko, Thomas J Kaley, et al.Journal of Neurosurgery|October 25, 2014
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewLeland Rogers, Igor Barani, Marc Chamberlain, et al.Journal of Neuro-Oncology|July 21, 2019
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Ingo K Mellinghoff, et al.Neurology|August 10, 2022
Combination Olaparib and Temozolomide for the Treatment of Glioma: A Retrospective Case SeriesLauren R Schaff, Marina Kushnirsky, Andrew L Lin, et al.Pigment Cell & Melanoma Research|July 3, 2024
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumabSarah E Lochrin, Darren J Buonocore, Robert J Young, et al.Annals of Clinical and Translational Neurology|April 16, 2020
Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastomaThomas J Kaley, Katherine S Panageas, Elena I Pentsova, et al.Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.Blood|January 9, 2015
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphomaAntonio Omuro, Denise D Correa, Lisa M DeAngelis, et al.Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.Pageof 5